Rockwell Medical, Inc. (RMTI): who owns it and who trades it
As of Nov 12, 2026, RMTI insiders reported 4 open-market sales worth $16K and no purchases in the last 12 months, with 72% of the sale value made under pre-set 10b5-1 plans. The largest seller was Mark Strobeck (CEO), with $8.4K. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 12, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Rockwell Medical
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, RMTI insiders reported $0 of open-market purchases and $16K of sales. 72% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Mark Strobeck | CEO | Sale plan | 1,000 | $8.42 | $8.4K | Form 4 |
| Jan 2, 2026 | Heather Hunter | Chief Operating Officer | Sale plan | 2,868 | $0.84 | $2.4K | Form 4 |
| Jan 2, 2026 | Jesse Neri | CFO | Sale plan | 886 | $0.84 | $744 | Form 4 |
| Nov 18, 2025 | John G Cooper | Director | Sale | 5,079 | $0.87 | $4.4K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Mark Strobeck | President and CEO, Director | – | $8.4K | Oct 1, 2026 |
| John G Cooper | Director | – | $4.4K | Nov 18, 2025 |
| Heather Hunter | Chief Operating Officer | – | $2.4K | Jan 2, 2026 |
| Jesse Neri | SVP and CFO | – | $744 | Jan 2, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
RMTI short interest
Low short interest. 0.9% of RMTI shares are sold short: about 1 share in 113. Over the last 12 reports the number of shares short went down 93%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 35,533 RMTI shares were sold short, 0.9% of the shares outstanding, down 49.3% from the report before. At the average daily volume of 24,708 shares, buying them all back would take about 1.4 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 35,533 | 0.88% | -49% | 24,708 | 1.4 |
| Oct 15, 2026 | 70,068 | 1.74% | -1% | 31,666 | 2.2 |
| Sep 30, 2026 | 70,807 | 1.76% | -21% | 19,935 | 3.5 |
| Sep 15, 2026 | 89,869 | 2.23% | -3% | 19,575 | 4.6 |
| Aug 31, 2026 | 92,980 | 2.31% | +6% | 27,157 | 3.4 |
| Aug 14, 2026 | 88,030 | 2.18% | -11% | 32,924 | 2.7 |
| Jul 31, 2026 | 98,502 | 0.25% | +15% | 33,098 | 3.0 |
| Jul 15, 2026 | 85,486 | 0.22% | -89% | 42,968 | 2.0 |
| Jun 30, 2026 | 803,271 | 2.04% | +9% | 396,218 | 2.0 |
| Jun 15, 2026 | 734,278 | 1.86% | +91% | 386,686 | 1.9 |
| May 29, 2026 | 383,990 | 0.97% | -22% | 251,796 | 1.5 |
| May 15, 2026 | 491,297 | 1.25% | +27% | 297,527 | 1.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Rockwell Medical company events
Rockwell Medical filed 14 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership, listing). The latest was on Nov 3, 2026.
- Nov 3, 2026AgreementRockwell Medical, Inc. entered into an Equity and Asset Purchase Agreement with Vantive Limited, a company incorporated under the laws of Jersey. Filing
- Aug 13, 2026AnnouncementShared information with investors. Filing
- Aug 13, 2026ResultsReleased financial results. Filing
- Jul 20, 2026AnnouncementRockwell Medical, Inc. received a written notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ('Nasdaq') indicating that the Company has regained compliance with the minimum $1.00 per share bid price requirement for continued listing on The Nasdaq Capital Market… Filing
- Jun 29, 2026SharesChanged the rights of its shareholders. Filing
- Jun 15, 2026VoteReported shareholder vote results. Filing
- May 8, 2026ListingRockwell Medical, Inc. received written notice from the Nasdaq Stock Market LLC notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Filing
- May 7, 2026AnnouncementShared information with investors. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Mar 26, 2026AnnouncementShared information with investors. Filing
- Mar 26, 2026ResultsReleased financial results. Filing
- Jan 20, 2026ResultsReleased financial results. Filing
- Jan 5, 2026AnnouncementRockwell Medical, Inc. and DaVita, Inc. entered into the Second Amendment to the Amended and Restated Products Purchase Agreement, dated as of September 18, 2023, as amended effective as of March 31, 2025, which extended the term of the Agreement by one year to December 31, 2026. Filing
- Nov 18, 2025LeadershipAndrea Heslin Smiley resigned from the Board of Directors of Rockwell Medical, Inc. and all Board committees on which she served, effective immediately. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Rockwell Medical financials
Famous investors that hold RMTI
1 of the 50 well-known investors we track reported holding RMTI in their latest 13F filing. The largest position is Jim Simons's, worth $306K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 35,864 | $306K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Rockwell Medical, Inc. (RMTI) stock
Are RMTI insiders buying or selling?
In the last 12 months, RMTI insiders reported no open-market purchases and 4 sales worth $16K. The latest trade was on Oct 1, 2026. See every trade.
What is the short interest in RMTI?
As of Oct 30, 2026, 35,533 RMTI shares were sold short, 0.9% of the shares outstanding, down 49.3% from the report before. At the average daily volume of 24,708 shares, buying them all back would take about 1.4 trading days (days to cover). See the history.
Which famous investors hold RMTI?
1 of the 50 well-known investors we track reported RMTI in their latest 13F filing, including Jim Simons. The largest position is worth $306K. See all holders.
Executive pay
Rockwell Medical's chief executive was paid a total of $1.9M for the year ended Dec 31, 2025, up 45% from $1.3M the year before. In the last 12 months, Rockwell Medical's executives and directors bought no stock on the open market and sold $16K.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.